Literature DB >> 19752784

[MR Imaging of primary ovarian tumors with pathologic correlation].

E Bouic-Pagès1, H Perrochia, S Mérigeaud, P Y Giacalone, P Taourel.   

Abstract

Ovarian tumors are classified based on the cell of origin into epithelial tumors, germ cell tumors and sex cord-stromal tumors. This pictorial essay illustrates the MR imaging features of the main ovarian tumors with pathologic correlation. These key features are helpful to suggest a specific diagnosis or narrow the differential diagnosis, in order to optimize the surgical approach.

Entities:  

Mesh：

Year:  2009        PMID： 19752784     DOI： 10.1016/s0221-0363(09)73210-x

Source DB:  PubMed          Journal:  J Radiol        ISSN： 0221-0363


  5 in total

1.  Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation.

Authors:  Sung Bin Park; Min-Jeong Kim; Kyoung Ho Lee; Yousun Ko
Journal:  Br J Radiol       Date:  2018-06-21       Impact factor: 3.039

2.  MR-PET fusion imaging in evaluating adnexal lesions: a preliminary study.

Authors:  V Fiaschetti; F Calabria; S Crusco; A Meschini; F Nucera; O Schillaci; G Simonetti
Journal:  Radiol Med       Date:  2011-09-02       Impact factor: 3.469

3.  The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns.

Authors:  Yen Zhi Tang; Sid Liyanage; Priya Narayanan; Anju Sahdev; Aslam Sohaib; Naveena Singh; Andrea Rockall
Journal:  Eur Radiol       Date:  2012-07-20       Impact factor: 5.315

4.  Imaging appearance of petrous apex dermoid cysts containing little or no fat.

Authors:  Naomi Ageshio; Taro Shimono; Takeo Goto; Kenji Ohata; Masahiko Ohsawa; Kenichi Wakasa; Yukio Miki
Journal:  Jpn J Radiol       Date:  2012-10-17       Impact factor: 2.374

5.  Benign and Suspicious Ovarian Masses-MR Imaging Criteria for Characterization: Pictorial Review.

Authors:  A L Valentini; B Gui; M Miccò; M C Mingote; A M De Gaetano; V Ninivaggi; L Bonomo
Journal:  J Oncol       Date:  2012-03-22       Impact factor: 4.375
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.